NFKB1 and pertussis: Studies have shown that the binding of the pertussis vaccine could activate the NF-κB signaling, promoting the production of a variety of cytokines, which not only can act on antibody generation but also can induce the activation of dendritic cells, thus affecting the overall adaptive immune response process [15].